{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:34:28Z","timestamp":1791124468588,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6726","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1038\/18877","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:39:24Z","timestamp":1027672764000},"page":"417-422","source":"Crossref","is-referenced-by-count":281,"title":["Synthesis of thrombin-inhibiting heparin mimetics without side effects"],"prefix":"10.1038","volume":"398","author":[{"given":"Maurice","family":"Petitou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pascal","family":"H\u00e9rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Bernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alexandre","family":"Driguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Duchaussoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Lormeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF18877_CR1","volume-title":"Heparin","author":"DA Lane","year":"1989","unstructured":"Lane, D. A. & Lindahl, U. (eds) Heparin (Arnold, London, (1989)."},{"key":"BF18877_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2165\/00003495-199040040-00003","volume":"40","author":"M Verstraete","year":"1990","unstructured":"Verstraete, M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 40, 498\u2013530 (1990).","journal-title":"Drugs"},{"key":"BF18877_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0037-1614206","volume":"79","author":"TE Warkentin","year":"1998","unstructured":"Warkentin, T. E., Chong, B. H. & Greinacher, A. Heparin-induced thrombocytopenia: Towards consensus. Thromb.. Hemost. 79, 1\u2013 7 (1998).","journal-title":"Thromb.. Hemost."},{"key":"BF18877_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1055\/s-0038-1665426","volume":"78","author":"DP Thomas","year":"1997","unstructured":"Thomas, D. P. Does low molecular weight heparin cause less bleeding? Thromb. Haemost. 78, 1422\u20131425 ( 1997).","journal-title":"Thromb. Haemost."},{"key":"BF18877_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/anie.198201553","volume":"21","author":"H Paulsen","year":"1982","unstructured":"Paulsen, H. Advances in selective chemical syntheses of complex oligosaccharides. Angew. Chem. Int. Ed. Engl. 21, 155\u2013 173 (1982).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BF18877_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","volume":"116","author":"J Choay","year":"1983","unstructured":"Choay, J. et al. Structure\u2013activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa Activity. Biochem. Biophys. Res. Commun. 116, 492 (1983).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF18877_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/anie.199316713","volume":"32","author":"CAA van Boeckel","year":"1993","unstructured":"van Boeckel, C. A. A. & Petitou, M. The unique antithrombin binding domain of heparin: a lead to new synthetic antithrombotics. Angew. Chem. Int. Ed. Engl. 32, 1671\u20131690 (1993).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BF18877_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0065-2318(08)60067-0","volume":"43","author":"B Casu","year":"1985","unstructured":"Casu, B. Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 43, 51\u2013134 ( 1985).","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"BF18877_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-2007-1001928","volume":"20","author":"ST Olson","year":"1994","unstructured":"Olson, S. T. & Bj\u00f6rk, I. Regulation of thrombin activity by antithrombin and heparin. Semin. Thromb. Haemost. 20, 373\u2013409 (1994).","journal-title":"Semin. Thromb. Haemost."},{"key":"BF18877_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nsb0995-736","volume":"2","author":"PDJ Grootenhuis","year":"1995","unstructured":"Grootenhuis, P. D. J., Westerduin, P., Meuleman, D., Petitou, M. & van Boeckel, C. A. A. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity. Nature Struct. Biol. 2, 736\u2013 739 (1995).","journal-title":"Nature Struct. Biol."},{"key":"BF18877_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1042\/bj1750691","volume":"175","author":"TC Laurent","year":"1978","unstructured":"Laurent, T. C., Tengblad, A., Thunberg, L., H\u00f6\u00f6k, M. & Lindahl, U. The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem. J. 175, 691\u2013701 (1978).","journal-title":"Biochem. J."},{"key":"BF18877_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.78.2.829","volume":"78","author":"GM Oosta","year":"1981","unstructured":"Oosta, G. M., Gardner, W. T., Beeler, D. L. & Rosenberg, R. D. Multiple functional domains of the heparin molecule. Proc. Natl Acad. Sci. USA 78, 829\u2013833 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF18877_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1042\/bj2180725","volume":"218","author":"DA Lane","year":"1984","unstructured":"Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L. & Lindahl, U. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem. J. 218, 725\u2013732 (1984).","journal-title":"Biochem. J."},{"key":"BF18877_CR14","doi-asserted-by":"crossref","first-page":"15467","DOI":"10.1016\/S0021-9258(18)66735-3","volume":"261","author":"A Danielsson","year":"1986","unstructured":"Danielsson, A., Raub, E., Lindahl, U. & Bj\u00f6rk, I. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J. Biol. Chem. 261, 15467\u201315473 (1986).","journal-title":"J. Biol. Chem."},{"key":"BF18877_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0960-894X(00)80585-5","volume":"2","author":"J Basten","year":"1992","unstructured":"Basten, J. et al. Biologically active heparin-like fragments with a \u201cnon-glycosamino\u201d glycan structure. Part 3: O -alkylated-O -sulphated pentasaccharides. Bioorg. Med. Chem. Lett. 2, 905\u2013 910 (1992).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BF18877_CR16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1021\/jm960726z","volume":"40","author":"M Petitou","year":"1997","unstructured":"Petitou, M. et al. Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A\/ORG 31540). J. Med. Chem. 40, 1600\u20131607 (1997).","journal-title":"J. Med. Chem."},{"key":"BF18877_CR17","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/(SICI)1521-3773(19981116)37:21<3009::AID-ANIE3009>3.0.CO;2-F","volume":"37","author":"M Petitou","year":"1998","unstructured":"Petitou, M. et al. First synthetic carbohydrates with the full anticoagulant properties of heparin. Angew. Chem. Int. Ed. Engl. 37, 3009\u20133014 (1998).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BF18877_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/01.RES.79.3.590","volume":"76","author":"J-M Herbert","year":"1996","unstructured":"Herbert, J.-M. et al . Biochemical and pharmacological properties of SANORG 32701. Comparison with the \u201csynthetic pentasaccharide\u201d (SR 90107A\/ORG 31540) and standard heparin. Circ. Res. 76, 590\u2013600 (1996).","journal-title":"Circ. Res."},{"key":"BF18877_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0038-1646657","volume":"39","author":"T Umetsu","year":"1978","unstructured":"Umetsu, T. & Sanai, K. Effect of KC-6141, an anti-aggregating compound, on experimental thrombosis in rats. Thromb. Haemost. 39, 74\u201383 ( 1978).","journal-title":"Thromb. Haemost."},{"key":"BF18877_CR20","doi-asserted-by":"publisher","first-page":"14683","DOI":"10.1073\/pnas.94.26.14683","volume":"94","author":"J Jin","year":"1997","unstructured":"Jin, J. et al. The anticoagulant activation of antithrombin by heparin. Proc. Natl Acad. Sci. USA 94, 14683\u201314688 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF18877_CR21","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0968-0896(00)82078-7","volume":"2","author":"P Westerduin","year":"1994","unstructured":"Westerduin, P. et al . Feasible synthesis and biological properties of six \u201cnon-glycosamino\u201d glycan analogues of the antithrombin III binding heparin pentasaccharide. Bioorg. Med. Chem. 2, 1267\u2013 1280 (1994).","journal-title":"Bioorg. Med. Chem."},{"key":"BF18877_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0968-0004(00)88945-8","volume":"20","author":"MT Stubbs","year":"1995","unstructured":"Stubbs, M. T. & Bode, W. The clot thickens: clues provided by thrombin structure. Trends Biochem. Sci. 20, 23\u201328 (1995).","journal-title":"Trends Biochem. Sci."},{"key":"BF18877_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0049-3848(82)90086-X","volume":"25","author":"E Sache","year":"1982","unstructured":"Sache, E. et al. Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin. Thromb. Res. 25, 443\u2013458 (1982).","journal-title":"Thromb. Res."},{"key":"BF18877_CR24","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/S0021-9258(18)38124-9","volume":"266","author":"ST Olson","year":"1991","unstructured":"Olson, S. T., Halvorson, H. R. & Bj\u00f6rk, I. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and non-specific binding models. J. Biol. Chem. 266, 6342\u2013 6352 (1991).","journal-title":"J. Biol. Chem."},{"key":"BF18877_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/glycob\/3.3.271","volume":"3","author":"M Maccarana","year":"1993","unstructured":"Maccarana, M. & Lindahl, U. Mode of interaction between platelet factor 4 and heparin. Glycobiology 3, 271 \u2013277 (1993).","journal-title":"Glycobiology"},{"key":"BF18877_CR26","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1021\/bi00394a024","volume":"26","author":"DH Atha","year":"1987","unstructured":"Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D. & Choay, J. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. Biochemistry 26, 6454\u2013 6461 (1987).","journal-title":"Biochemistry"},{"key":"BF18877_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","volume":"67","author":"D Sheridan","year":"1986","unstructured":"Sheridan, D., Carter, C. & Kelton, J. G. Adiagnostic test for heparin-induced-thrombocytopenia. Blood 67, 27\u201330 (1986).","journal-title":"Blood"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/18877.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/18877","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/18877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/18877.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T23:20:54Z","timestamp":1638400854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/18877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":27,"journal-issue":{"issue":"6726","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["BF18877"],"URL":"https:\/\/doi.org\/10.1038\/18877","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}